Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes-Reference-Cited by-同舟云学术

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes

Published:2015-02 Issue:2 Volume:63 Page:267-272
ISSN:1081-5589
Container-title:Journal of Investigative Medicine
language:en
Short-container-title:Journal of Investigative Medicine

Author:

Xu Weijie,Yang Yan,Yuan Gang,Zhu Wenjun,Ma Delin,Hu Shuhong

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference44 articles.

1. The development of effective biomarkers for Alzheimer's disease: a review

2. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

3. Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5

4. Tau protein kinases: Involvement in Alzheimer's disease

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

2. Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets;Cell Biochemistry and Function;2024-09-03

3. The GLP-1R Agonist Exenatide Improves Sheep Sperm Motility by Regulating Cellular Metabolic Levels;2024-08-12

4. The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade;International Immunopharmacology;2024-06

5. Pharmacotherapy for older people with obesity;European Journal of Internal Medicine;2024-06